Exane Derivatives’s iShares S&P 500 Value ETF IVE Stock Holding History
Bought
Maintained
Sold
Other funds holding IVE
Exane Derivatives's IVE Position: Q1 2022 in Review
Exane Derivatives sold out of iShares S&P 500 Value ETF (IVE) in Q1 2022, closing a stake of 52,550 shares — an estimated $8.23M sold.
Exane Derivatives first reported a position in IVE in Q1 2021 and held it in 4 quarters. The position peaked at $8.73M in Q2 2021. 1,073 funds tracked by Wall St. Rank hold IVE as of Q1 2022.
- Exane Derivatives reported no remaining iShares S&P 500 Value ETF position as of Q1 2022 after selling out during the quarter.
- Exane Derivatives sold 52,550 iShares S&P 500 Value ETF shares in Q1 2022, an estimated $8.23M.
- Exane Derivatives first reported a position in iShares S&P 500 Value ETF in Q1 2021 and held it in 4 quarters.
- Exane Derivatives's iShares S&P 500 Value ETF position peaked at $8.73M in Q2 2021.
- 1,073 funds tracked by Wall St. Rank held iShares S&P 500 Value ETF as of Q1 2022.
Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.